Implementation Science and Health Outcomes Core
实施科学与健康成果核心
基本信息
- 批准号:10090641
- 负责人:
- 金额:$ 23.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-09-30 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS clinical trial groupAIDS preventionAIDS/HIV problemAddressAdherenceAffinityAfrica South of the SaharaAreaBiomedical TechnologyCaringCitiesClinical ResearchClinical effectivenessCollaborationsCommunity Health SystemsConsultationsContinuity of Patient CareDiagnosisDisciplineDoctor of MedicineDoctor of PhilosophyEffectivenessEpidemicEpidemiologistEpidemiologyEvidence based interventionFosteringFundingGap JunctionsGeographic LocationsHIVHIV diagnosisHealthHealth PolicyHealthcare SystemsInstitutesInterventionLinkMental HealthMental disordersMentorsModelingNew YorkOutcomePoliciesPolicy AnalysisPolicy MakerPopulation AnalysisPreventionProphylactic treatmentPsychiatristPsychiatryPublic HealthResearchResearch DesignResearch InfrastructureResearch PersonnelScienceScientistStructureTestingTimeTranslationsUnited States National Institutes of HealthUniversitiesViralVulnerable Populationsbehavioral studybehavioral/social sciencecareerclinical centercomorbidityeconomic evaluationeffectiveness implementation studyeffectiveness researchevidence basehealth disparityimplementation interventionimplementation researchimplementation scienceimprovedinnovationinterdisciplinary collaborationinterestlow and middle-income countriesnovel strategiespopulation basedpopulation healthpractice settingpre-exposure prophylaxispreventprogramsresearch studyscale upscreeningsubstance useuptakeworking group
项目摘要
Although millions of lives have been saved by new biomedical technologies and expansion of prevention
and treatment in low- and middle-income countries, many vulnerable people – including in the US – are not
benefiting from these advances. Implementation science (IS) research can maximize public health impact by
addressing suboptimal implementation of evidence-based strategies; identifying ways in which health care
systems and policies fail to adequately address the HIV prevention and care continua; and identifying
population-based strategies to improve HIV outcomes in the US and globally. The Implementation Science
and Health Outcomes (ISHO) Core will address the HIV Center's overall theme by catalyzing innovative IS
research that identifies and tests strategies to optimize “real-world” uptake and impact of effective HIV
prevention and care continua interventions at scale. The Core has three Specific Aims: (1) to stimulate new IS
research and collaborations to improve key outcomes along the HIV prevention and care continua; (2) to
advance new IS research to prevent or reduce HIV-related health disparities that are driven by suboptimal
intervention implementation or by psychiatric and other comorbidities; and (3) to promote the use of health
policy analysis, policy modeling, and economic evaluation to bridge the evidence-practice and evidence-policy
gaps that drive suboptimal population-based implementation and disparities.
The ISHO Core will accomplish its Aims through functions that include (1) providing expert consultation to
HIV Center researchers on conducting IS research that (a) both tests new approaches to improve HIV-related
programmatic outcomes and assesses causes of successful and un-successful implementation of interventions
and policies at scale, and (b) incorporates the perspectives of policy translation, policy modeling, and
economic evaluation into their research; (2) developing Scientific Working Groups to provide structured and
focused guidance to (and collaboration with) Center investigators interested in or embarking on IS through
dynamic small groups organized around specific themes (e.g., PrEP implementation, psychiatric
comorbidities); (3) facilitating access to linked networks for HIV Center investigators addressing IS-related
research questions; and (4) sponsoring seminars to stimulate the use of IS approaches in research. The
proposed Core Director, Denis Nash, Ph.D., is an epidemiologist and Director of the Institute for
Implementation Science in Population Health (ISPH) at the City University of New York. Core Co-Director,
Milton Wainberg, M.D., is a research psychiatrist at the New York State Psychiatric Institute and Columbia
University Department of Psychiatry. Together they have extensive expertise in NIH-funded research and
capacity building for HIV and mental health treatment and prevention. The Core brings together early stage,
mid-career, and established investigators in the areas of IS, health-disparities, and economic evaluation with
policy-makers and program implementers to provide an infrastructure for research collaboration.
尽管新的生物医学技术和扩大预防措施拯救了数百万人的生命
低收入和中等收入国家的治疗和治疗,许多弱势群体 — — 包括美国的 — — 并没有受到影响
受益于这些进步,实施科学(IS)研究可以通过以下方式最大限度地提高公共卫生影响。
解决基于证据的策略实施欠佳的问题;确定卫生保健的方式;
系统和政策未能充分解决艾滋病毒预防和护理问题;
以人口为基础的战略,以改善美国和全球的艾滋病毒结果。
和健康成果 (ISHO) 核心将通过促进创新 IS 来解决艾滋病毒中心的总体主题
研究确定和测试优化“现实世界”有效艾滋病毒的吸收和影响的策略
大规模的预防和护理连续干预措施具有三个具体目标:(1) 刺激新的信息系统。
研究和合作以改善艾滋病毒预防和护理连续性的关键成果(2)
新的 IS 研究旨在预防或减少由次优导致的与艾滋病毒相关的健康差异
实施干预措施或针对精神科和其他合并症;以及 (3) 促进健康的使用;
政策分析、政策建模和经济评估,以连接证据-实践和证据-政策
导致基于人口的实施欠佳和差异的差距。
ISHO 核心将通过以下职能实现其目标:(1) 向
HIV 中心研究人员进行的 IS 研究 (a) 均测试了改善 HIV 相关问题的新方法
规划成果并评估成功和不成功实施干预措施的原因
和大规模的政策,并且(b)纳入了政策转化、政策建模的观点,以及
对他们的研究进行经济评估;(2) 建立科学工作组,以提供结构化和
通过以下方式向对信息系统感兴趣或着手信息系统的中心调查人员提供集中指导(并与之合作):
围绕特定主题(例如 PrEP 实施、精神病学
(3) 为艾滋病毒中心调查人员访问链接网络提供便利,以解决与伊斯兰国相关的问题
研究问题;(4) 主办研讨会以促进信息系统方法在研究中的应用。
拟议的核心主任丹尼斯·纳什博士是一名流行病学家兼研究所所长
纽约城市大学人口健康实施科学 (ISPH) 核心联合主任。
米尔顿·温伯格(Milton Wainberg),医学博士,纽约州精神病学研究所和哥伦比亚大学心理学研究人员
他们在 NIH 资助的研究和研究方面拥有广泛的专业知识。
艾滋病毒和心理健康治疗和预防的能力建设汇集了早期阶段、
职业中期,并在信息系统、健康差异和经济评估领域建立了调查员
政策制定者和计划实施者为研究合作提供基础设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Denis Nash其他文献
Denis Nash的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Denis Nash', 18)}}的其他基金
Developing Statistical Methods on Event History Data Subject to Data Complexities for HIV Disease Progression and Policy Evaluation
根据艾滋病毒疾病进展和政策评估的数据复杂性,开发事件历史数据的统计方法
- 批准号:
10700452 - 财政年份:2023
- 资助金额:
$ 23.17万 - 项目类别:
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
- 批准号:
10762607 - 财政年份:2023
- 资助金额:
$ 23.17万 - 项目类别:
Brief digital intervention to increase COVID-19 vaccination among individuals with anxiety or depression
简短的数字干预措施可增加焦虑或抑郁患者的 COVID-19 疫苗接种
- 批准号:
10613750 - 财政年份:2022
- 资助金额:
$ 23.17万 - 项目类别:
相似国自然基金
去医学化综合性艾滋病暴露前预防决策支持系统及优化
- 批准号:72364039
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
新策略下我国艾滋病预防干预措施效果评估动态模型的构建和应用
- 批准号:81803334
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于系统动力学的预防艾滋病经家庭内传播研究
- 批准号:71774150
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
基于创新扩散理论的广西农村校外青少年预防艾滋病互联网+健康教育干预研究
- 批准号:71663013
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:地区科学基金项目
基于社会心理-行为协同效应的男男性行为者预防艾滋病干预措施及策略研究
- 批准号:71603166
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Tecovirimat 针对人猴痘病毒 (STOMP) 的研究
- 批准号:
10689623 - 财政年份:2022
- 资助金额:
$ 23.17万 - 项目类别:
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
CoVPN 3008 COVID-19 mRNA 疫苗在 SARS-CoV-2 变异关注地区的 3 期、多中心、随机、功效研究
- 批准号:
10493538 - 财政年份:2022
- 资助金额:
$ 23.17万 - 项目类别:
PHASE I STUDY OF PHARMACOKINETICS, SAFETY AND ACCEPTABILITY OF A SINGLE DOSE OF PRETOMANID ADDED TO AN OPTIMIZED BACKGROUND REGIMEN IN CHILDREN WITH RIFAMPICIN RESISTANT TUBERCULOSIS IMPAACT 2034
对患有利福平耐药结核病儿童的单剂量 Pretomanid 的药代动力学、安全性和可接受性的 I 期研究添加到优化背景方案中的影响 2034
- 批准号:
10679271 - 财政年份:2022
- 资助金额:
$ 23.17万 - 项目类别:
A randomized controlled pilot study to examine the impact of a filmed dramatized story intervention (telenovela/soap opera) for HIV prevention in Latinas
一项随机对照试点研究,旨在检验电影化故事干预(电视剧/肥皂剧)对拉丁裔艾滋病毒预防的影响
- 批准号:
10403030 - 财政年份:2022
- 资助金额:
$ 23.17万 - 项目类别: